AB025. Asian men’s sexual health: Korean perspective

Sexual function is an important component of men’s health. The prevalence of erectile dysfunction (ED) in Korea has been reported as 18–36.6% whereas Asian data showed a wide range from 2% to 88%. In 2013, the Korean Society for Sexual Medicine and Andrology (KSSMA) developed the Korean Guideline of ED. Risk factors for ED included age, diabetes, hypertension, obesity, lack of exercise, dyslipidemia, smoking, depression, lower urinary tract symptoms, and pelvic surgery. This guideline showed that lifestyle changes and modification of risk factors should be educated along with specific treatment of ED, such as pharmacological treatment. In Korea, there are many oral phosphodiesterase type 5 (PDE5) inhibitors on market such as sildenafil, vardenafil, tadalafil, udenafil, mirodenafil, avanafil, and also generic versions of sildenafil and tadalafil. The guideline showed that the choice of PDE5 inhibitors should be based on the patient’s experience under a physician’s guidance regarding the characteristics of each PDE5 inhibitors. The prevalence of c in Korea has been reported to be around 11.3% to 33%. Recent Korean nationwide survey showed that the main treatment modality for PE patients was selective-serotonin reuptake inhibitor (SSRI) therapy such as dapoxetine, dorsal nerve neurectomy, local anesthetics and behavior therapy. The sexual health is a crucial part of men’s health. Therefore, it is needed to develop a strategy to improve sexual health for better life in Asian men.